Life sciences – including new cancer treatments – forms a central pillar of the UK Government’s post-Brexit plan for science and technology. But how could this focus also play a role in another key tenet of British policymaking; the levelling-up agenda? In this blog, adapted from our On Cancer publication, Professor Fiona Thistlethwaite and Professor […]
![](https://blog.policy.manchester.ac.uk/wp-content/uploads/2022/11/221115-On-Cancer-NW-life-sciences-featured-image-680x280-1-680x280.jpg)